Alliqua BioMedical (NASDAQ: ALQA) develops and manufactures electron-beam cross-linked sheet gels for customers that include manufacturers of medical devices, cosmeceuticals, and other commercial product applications.

Our hydrogel platform technology allows us to manufacture electron-beam cross-linked sheet gels with or without active ingredients. Prescription or over-the-counter medications, ingredients for wound healing and skin care, or other materials, can be effectively delivered using our platform. We currently provide custom hydrogels to the original equipment manufacturer market.

Alliqua operates a 16,000 square foot GMP manufacturing facility in Langhorne, PA that allows for the development and custom manufacture of a wide variety of hydrogels. Our ability to meet the varying specifications of our customers’ needs, maintain tight tolerances, ensure prompt delivery, and provide superior customer service have made Alliqua the leader in the cross-linked hydrogel market.